Flagship Ventures Fund IV-Rx, L.P., 10% Owner, Director at Moderna, Inc. (MRNA), sold 7,142,727 shares at $18.99 ($16.0M) on 2019-12-09, disclosed to the SEC on 2019-12-11.
Open-market sale of $16.0M MRNA by 10% Owner, Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 6,292,342 | $0 | 0.0% |
| 2 | $18.99 | 27,714 | $526K | 3.3% |
| 3 | $18.99 | 27,714 | $526K | 3.3% |
| 4 | $18.99 | 144,423 | $2.7M | 17.2% |
| 5 | $18.99 | 144,423 | $2.7M | 17.2% |
| 6 | $18.96 | 4,092 |
| $78K |
| 0.5% |
| 7 | $18.96 | 4,092 | $78K | 0.5% |
| 8 | $18.96 | 21,325 | $404K | 2.5% |
| 9 | $18.65 | 38,366 | $716K | 4.5% |
| 10 | $18.65 | 38,366 | $716K | 4.5% |
| 11 | $18.65 | 199,935 | $3.7M | 23.3% |
| 12 | $18.65 | 199,935 | $3.7M | 23.3% |
| Total | $2.24 avg | 7,142,727 | $16.0M | 100% |
| Filing → |